Development and characterization of compressed odt formulation of insoluble low bitter drug

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 2, 2010, Pages 102-106

  Venkata Ramana Reddy, S ^a   Dondeti, Sathyanarayana ^a   Manavalan, R ^a   Sreekanth, J ^b  

^a ANNAMALAI UNIVERSITY   (India)

^b NATCO   (India)

Author keywords

Diluent; Direct compression; Oral disintegrating tablets (ODTs); Superdisintegrant; Taste enhancers; Zaleplon

Indexed keywords

ACESULFAME; ASPARTAME; CROSPOVIDONE; DODECYL SULFATE SODIUM; MANNITOL; PEPPERMINT; PLACEBO; SILICON DIOXIDE; ZALEPLON;

ARTICLE; BITTER TASTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; NORMAL HUMAN; PALATABILITY; RANDOMIZED CONTROLLED TRIAL; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; VOLUNTEER;

EID: 77953417963     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Guidance for industry oral disintegrating tablets published by centre for drug evaluation and research, accessed at http://www.fda.gov/cder/guidance/index.htm
2. http://www.FDA.gov-CDERDatastandardsmanual.
3. European Pharmacopeia; 2006, p.3151-56.
4. Bradoo R, Shahani S, Poojary S, Deewan B and Sudarsan S, Fast Dissolving drug Delivery Systems. JAMA 2001; 4; p.27-31.
5. Dobetti L, Fast -Melting Tablets: Development and Technologies, Pharm Tech 2001; 37; p.44-50.
6. Lorenzp-Lamosa M L, Cuna M, Vila-Jato JL and Torres D. Fast Dissolving Drug Delivery Systems: An Update. J Microencapsul, 1997; 14; p.607-631.
7. Caraballo I, Fernandez-Arevalo M and Millan M. Superdisintegrants in Tablet Formulations. Drug Dev Ind Pharm 1997; 23; p.665-669.
8. Rx list, the internet drug index. Sonata (Zaleplon capsules) Drug description and clinical pharmacology (Last updated on Rx list: 1/2/2008).
9. FDA/Center for Drug Evaluation and Research, Office of Generic Drugs, Division of Bioequivalence, Dissolution methods of Zaleplon. Data Current through: October 7, 2009.